C22H44N6O10
Neat
552.63
Arbekacin; 51025-85-5; Arbekacina; Haberacin; Arbekacine; Arbekacinum; G7V6SLI20L; ME1100; ME-1100; NPC-14; (2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-4-[(2R, 3R, 6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S, 3R, 4S, 5S, 6R)-4-amino-3, 5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide; DTXSID8048319; CHEBI:37922; (2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-2-{[(2S, 3R, 4S, 5S, 6R)-4-amino-3, 5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R, 3R, 6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide; (2S)-4-amino-N-((1R, 2S, 3S, 4R, 5S)-5-amino-2-(((2S, 3R, 4S, 5S, 6R)-4-amino-3, 5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-4-(((2R, 3R, 6S)-3-amino-6-(aminomethyl)oxan-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide; (2S)-4-amino-N-((1R, 2S, 3S, 4R, 5S)-5-amino-4-((2R, 3R, 6S)-3-amino-6-(aminomethyl)oxan-2-yl)oxy-2-((2S, 3R, 4S, 5S, 6R)-4-amino-3 and 5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-3-hydroxycyclohexyl)-2-hydroxybutanamide; RefChem:113718; DTXCID0028294; 4-amino-2-hydroxybutylyldibekacin; J01GB12
(2S)-4-amino-N-[(1R, 2S, 3S, 4R, 5S)-5-amino-4-[(2R, 3R, 6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S, 3R, 4S, 5S, 6R)-4-amino-3 and 5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
InChI=1S/C22H44N6O10/c23-4-3-12(30)20(34)28-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)17(33)19(11)38-22-16(32)14(27)15(31)13(7-29)36-22/h8-19,21-22,29-33H,1-7,23-27H2,(H,28,34)/t8-,9+,10-,11+,12-,13+,14-,15+,16+,17-,18+,19-,21+,22+/m0/s1